|
We know that, as a clinician, you demand products that are validated by clinical evidence. Supported by more than 10 independent, peer-reviewed, published clinical studies, PhaSeal is the only clinically proven closed-system drug transfer device (CSTD) available today. As noted by clinical thought leaders across the US,
NIOSH ALERT Publication addresses workers in all healthcare settings and includes this warning:
|
|


|
|
|